Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer

Details for Australian Patent Application No. 2012202120 (hide)

Owner MedImmune Limited

Inventors Brown, Jeffrey Lester; Emery, Stephen Charles; Blakey, David Charles

Agent Davies Collison Cave

Pub. Number AU-A-2012202120

Parent 2011201326

Filing date 12 April 2012

Wipo publication date 3 May 2012

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/00 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202120

3 May 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202121-A mooring system

2012202119-Blister for inhalers